Header Logo
Last Name

Magdalena Bieniasz

TitleMember, Assistant
InstitutionOklahoma Medical Research Foundation
DepartmentFunctional and Chemical Genomics
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Medical University of Lodz, PolandMS2006Pharmaceutical Biochemistry
    Medical University of Lodz, PolandPhD2008Medical Biochemistry
    Roswell Park Cancer Institute, Buffalo, NYPostdoc Fellow2010Immunology
    Huntsman Cancer Institute, Salt Lake City, UTPostdoc Fellow2014Oncological Sciences

    Collapse Research 
    Collapse research activities and funding
    K22CA207602     (BIENIASZ, MAGDALENA)May 10, 2017 - Apr 30, 2020
    The role of short-form Ron (sfRon) kinase in the pathogenesis of high-grade serous ovarian cancer
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Moxley KM, Wang L, Welm AL, Bieniasz M. Short-form Ron is a novel determinant of ovarian cancer initiation and progression. Genes Cancer. 2016 May; 7(5-6):169-81. PMID: 27551332.
      View in: PubMed
    2. Bieniasz M, Radhakrishnan P, Faham N, De La O JP, Welm AL. Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts. Clin Cancer Res. 2015 Dec 15; 21(24):5588-600. PMID: 26289070.
      View in: PubMed
    3. Liu X, Zhao L, Derose YS, Lin YC, Bieniasz M, Eyob H, Buys SS, Neumayer L, Welm AL. Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase. Genes Cancer. 2011 Jul; 2(7):753-62. PMID: 22207901.
      View in: PubMed
    4. Gil M, Bieniasz M, Wierzbicki A, Bambach BJ, Rokita H, Kozbor D. Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice. J Immunol. 2009 Nov 15; 183(10):6808-18. PMID: 19846865.
      View in: PubMed
    5. Bieniasz M, Oszajca K, Eusebio M, Kordiak J, Bartkowiak J, Szemraj J. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer. 2009 Dec; 66(3):319-26. PMID: 19324447.
      View in: PubMed
    6. Jamroziak K, Szemraj Z, Grzybowska-Izydorczyk O, Szemraj J, Bieniasz M, Cebula B, Giannopoulos K, Balcerczak E, Jesionek-Kupnicka D, Kowal M, Kostyra A, Calbecka M, Wawrzyniak E, Mirowski M, Kordek R, Robak T. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):945-53. PMID: 19240243.
      View in: PubMed
    7. Oszajca K, Bieniasz M, Brown G, Swiatkowska M, Bartkowiak J, Szemraj J. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Biochem Cell Biol. 2008 Dec; 86(6):477-86. PMID: 19088796.
      View in: PubMed
    8. Kowalski M, Brown G, Bieniasz M, Oszajca K, Chabielska E, Pietras T, Szemraj Z, Makandjou-Ola E, Bartkowiak J, Szemraj J. Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant. Acta Biochim Pol. 2009; 56(1):41-53. PMID: 19018330.
      View in: PubMed
    9. Bieniasz M, Bartkowiak J, Szemraj J. [Expression of bone morphogenetic proteins, matrix metalloproteinases and inhibitors of matrix metalloproteinases in lung cancers and their prognostic significance]. Postepy Biochem. 2008; 54(1):82-90. PMID: 18610585.
      View in: PubMed
    Bieniasz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description